Michael E. Faerm's Net Worth
$5.58 Million
Who is Michael E. Faerm?
Michael E. Faerm has an estimated net worth of $5.58 Million. This is based on reported shares across multiple companies, which include THERAVANCE INC, and Viracta Therapeutics, Inc..
SEC CIK
Michael E. Faerm's CIK is 0001647141
Past Insider Trading and Trends
2015 was Michael E. Faerm's most active year for acquiring shares with 1 total transactions. Michael E. Faerm's most active month to acquire stocks was the month of December. 2017 was Michael E. Faerm's most active year for disposing of shares, totalling 4 transactions. Michael E. Faerm's most active month to dispose stocks was the month of July. 2024 saw Michael E. Faerm paying a total of $0.00 for 500,000 shares, this is the most they've acquired in one year. In 2016 Michael E. Faerm cashed out on 12,437 shares for a total of $144,086.39, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Innoviva, Inc. (INVA) Snapshot price: $18.7201
Sr VP & Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.57% | -4.47K |
$13.17 | -$58,869.90 | 279.42K |
Nov 20
| |||
Form 4
| -1.11% | -3.18K |
$12.28 | -$39,038.12 | 283.89K |
Aug 20
| |||
Form 4
| -1.09% | -3.18K |
$11.86 | -$37,667.36 | 287.07K |
May 20
| |||
Form 4
| -2.00% | -5.86K |
$12.04 | -$70,554.40 | 287.75K |
Feb 20
| |||
Form 4
| +83.26% | 133.4K |
—
|
—
| 293.61K |
Jan 17
| |||
Form 4
| -1.77% | -2.89K |
$10.91 | -$31,562.63 | 160.21K |
Nov 20
| |||
Form 4
| -5.54% | -9.54K |
$11.79 | -$112,523.76 | 162.87K |
Aug 20
| |||
Form 4
| +63.75% | 67.13K |
—
|
—
| 172.41K |
Jan 14
| |||
Form 4
|
∞
| 105.29K |
—
|
—
| 105.29K |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Viracta Therapeutics, Inc. (VIRX) Snapshot price: $0.2301
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||